New platform to review unpublished studies


  • Mary Corcoran
  • Univadis Medical News
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

ASAPbio and EMBO Press have announced the launch of a new platform for high-quality, journal-independent peer review of manuscripts from the life sciences before they are submitted to a journal. 

Authors using the platform will be able to submit preprints or unpublished manuscripts to Review Commons for expert peer review. Reviewers will evaluate the technical rigour of the work, make suggestions for improvements and comment on the potential value of the work to specific communities. 

The author will be provided with a refereed preprint containing the manuscript, the reviewers’ reports and any author responses to help the authors to make an informed decision on the best way forward for their paper. 

The platform will also expedite submission to 17 affiliate journals that have agreed to consider the transferred reviews without restarting the review process, including PLOS One, eLife and EMBO Molecular Medicine. These journals have committed to use the Review Commons referee reports for their independent editorial decisions and to seek minimal additional expert input.

Those behind the project hope that the multi-journal partnership will accelerate scientific publishing by offering journal-independent peer review.